-
Mortality in COPD and Cardiovascular Disease Comorbidity: Survival Analysis Using Curated Data From Brazilian Public Healthcare System (SUS)
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life Measured by EQ-5D Utility Among Patients With TGCT: A Trial-Based Analysis of EQ-5D Data From Patients in the MOTION Trial
Sep 9, 2025, 16:22 PM -
Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Prevention of Respiratory Syncytial Virus Illness Among High-Risk Adults Aged 18-59 Years in Germany
Sep 9, 2025, 16:22 PM -
The Economic Burden of Acromegaly Disease in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
Epidemiology of Pulmonary Arterial Hypertension In France: A Real-World Study Using the French National Healthcare Database (SNDS)
Sep 9, 2025, 16:22 PM -
Qualitative Evaluation of an AI Tool for Opportunistic Detection of Vertebral Fractures in the National Health Service
Sep 9, 2025, 16:22 PM -
Estimating Life-Years and QALYs Gained From Tumor Treating Fields in Newly Diagnosed Glioblastoma: A US-Based Real-World Survival-Based Model
Sep 9, 2025, 16:22 PM -
Estimating the Mean Time in Treatment-Free Remission for Patients in Early Line CML
Sep 9, 2025, 16:22 PM -
Challenges in Defining Target Populations: An Analysis of Orphan Drug Health Technology Assessments in Germany 2024
Sep 9, 2025, 16:22 PM -
Health Economic Evaluation Model for Pancreatic Cancer Risk Management Through Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Sep 9, 2025, 16:22 PM -
Analysis of the Epidemiological Disease Burden of Endometriosis in Hungary Based on Data From the Global Burden of Disease Study
Sep 9, 2025, 16:22 PM -
Health Economic Assessment of Cefepime-Enmetazobactam for Treating Complicated Urinary Tract Infections: A German Payer Perspective
Sep 9, 2025, 16:22 PM -
Assessing Different Procurement Models for Automated Insulin Delivery (AID) Systems Using a Multicriteria Decision Analysis (MCDA)-Based Framework
Sep 9, 2025, 16:22 PM -
Limited Duration vs. Treat-to-Progression Approaches for New Therapies in Hemato-oncology: Impact at HTA
Sep 9, 2025, 16:22 PM -
From Theory to Practice: Guidance for Identifying and Selecting Mapping Algorithms for Health Economic Models
Sep 9, 2025, 16:22 PM -
When Less Is More? Learnings From a Recent NICE Submission Utilizing a Novel Predictive Individual-Level Surrogacy Approach to Predict Overall Survival (OS) in the Absence of Trial-Level Evidence
Sep 9, 2025, 16:22 PM -
Vignette-Based Economic Models in UK HTA Submissions: Valuable Tool or Just NICE in Theory?
Sep 9, 2025, 16:22 PM -
Cost Savings From Patient Preference-Based Allocation of High-Efficacy Therapies for MS: Evidence From Switzerland
Sep 9, 2025, 16:22 PM -
Real-World Outcomes From a Pharmacy-Based Awareness and Screening Campaign for HF and CKD: Insights From the Chronic Diseases From A to Z Program
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization Associated With Acute Pancreatitis in Patients With Familial Chylomicronemia Syndrome Treated With Olezarsen: A Post Hoc Analysis of Balance Study Data
Sep 9, 2025, 16:22 PM
